ClinicalTrials.Veeva

Menu

Efficacy of Combined Scaffolds and Sodium Hypochlorite in Regenerative Endodontics of Immature Teeth

T

Tanta University

Status

Enrolling

Conditions

Incomplete Root Formation of Anterior Teeth

Treatments

Other: Intra-canal medication protocol

Study type

Interventional

Funder types

Other

Identifiers

NCT05803525
HananArb

Details and patient eligibility

About

The aim of the study is to evaluate the efficacy of combinations of different scaffolds (blood clot, platelet rich fibrin, collagen) and sodium hypochlorite concentrations (0.5%- 2.5%) in regenerative endodontics of immature non-vital anterior teeth clinically and radiographically using cone-beam computed tomography.

Full description

Patients will be divided randomly into six equal groups (n=8)

  • Group I: BC scaffold and 0.5% concentration of NaOCl irrigant solution.
  • Group II: BC scaffold and 2.5% concentration of NaOCl irrigant solution.
  • Group III: PRF scaffold and 0.5% concentration of NaOCl irrigant solution.
  • Group IV: PRF scaffold and 2.5% concentration of NaOCl irrigant solution.
  • Group V: Collagen scaffold and 0.5% concentration of NaOCl irrigant solution.
  • Group VI: Collagen scaffold and 2.5% concentration of NaOCl irrigant solution.

CBCT image will be obtained for baseline records after placement of the final resin restoration then the patients will be recalled after 6 months and 12 months for evaluating any changes in root length, root canal width, apex diameter and lesion size if present. The success rates for patients at each recall visit will be scored as follows

  1. Score 0: Persistence of clinical and radiographic findings.
  2. Score 1: Absence of swelling, drainage and pain along with radiographic evidence of osseous healing + no evidence of increased root dimensions.
  3. Score 2: Absence of swelling, drainage and pain along with radiographic evidence of osseous healing + radiographic root development.

Enrollment

48 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • • Patients, abarantly free from any systemic diseases that may hinder the normal healing process.

    • Maxillary traumatized or cariously exposed immature anterior teeth.
    • Clinical signs of pulp necrosis.
    • Radiographic evidence of incomplete root development based on an apical opening >1 mm.

Exclusion criteria

  • • Allergy to medication used in the procedure or any medical conditions that contraindicate endodontic treatment (eg, acute systemic disease and abnormalities in host defense).

    • Non-restorable tooth.
    • Radiographic evidence of root fracture.
    • Lack of patient and parent cooperation.
    • Teeth with vital pulps and complete root development.
    • Presence of periodontal pocket > 4 mm.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

48 participants in 6 patient groups

• Group I: BC scaffold and 0.5% concentration of NaOCl irrigant solution.
Active Comparator group
Description:
BC will be made \& use 0.5 NaOCl conc
Treatment:
Other: Intra-canal medication protocol
• Group II: BC scaffold and 2.5% concentration of NaOCl irrigant solution. •
Active Comparator group
Description:
BC will be made \& use 2.5 NaOCl conc
Treatment:
Other: Intra-canal medication protocol
• Group III: PRF scaffold and 0.5% concentration of NaOCl irrigant solution. •
Active Comparator group
Description:
PRF will be made \& use 0.5 NaOCl conc
Treatment:
Other: Intra-canal medication protocol
Group IV: PRF scaffold and 2.5% concentration of NaOCl irrigant solution. •
Active Comparator group
Description:
PRF will be made \& use 2.5 NaOCl conc
Treatment:
Other: Intra-canal medication protocol
• Group V: Collagen scaffold and 0.5% concentration of NaOCl irrigant solution.
Active Comparator group
Description:
Collagen will be made \& use 0.5 NaOCl conc
Treatment:
Other: Intra-canal medication protocol
• Group VI: Collagen scaffold and 2.5% concentration of NaOCl irrigant solution.
Active Comparator group
Description:
Collagen will be made \& use 2.5 NaOCl conc
Treatment:
Other: Intra-canal medication protocol

Trial contacts and locations

1

Loading...

Central trial contact

Hanan Arb, M.S.D; Hanan Arb, M.S.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems